Scientists created an immunotherapy that tracks pancreatic cancer even after it spreads. The breakthrough treatment works in ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Chronic pancreatitis is now recognized as a complex fibroinflammatory disorder involving genetic, environmental, and metabolic factors.

Last month, the United States Food and Drug Administration (FDA) approved a new wearable device for treating pancreatic cancer. This device, called Optune | Cancer ...

The therapy shows efficacy in improving diarrhea, abdominal pain in GLP-1, GLP-1/GIP-treated patients with diabetes and/or obesity in a small study.

Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...

For the 14th year, the Marquette women's lacrosse team will hold their Pancreatic Cancer Awareness Game when they host Georgetown on March 21.Golden Eagles Head Coach Meredith Black ...

If you or someone you love has been diagnosed with type 1 diabetes (T1D), a genuine miracle is on the horizon: a type 1 diabetes cure. Newly released findings show that all 10 initial participants ...

AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM” or the "Company”) today announced that the Japan Patent Office has fully ...

Verastem (VSTM) stock receives a "Buy" rating, driven by progress in KRAS G12D-targeted therapies and multiple 2026 catalysts. Read the full analysis here.

As a researcher, I still remember the discomfort I felt every time I had to sacrifice laboratory animals for an experiment.

Researchers have identified a specific hormone produced by pancreatic beta cells as a direct driver of obesity-linked pancreatic cancer in mouse models, shifting scientific attention away from insulin ...